AVANIR Pharma Offers Three Presentations for AVP-825 for Acute Treatment of Migraine
June 24, 2014 at 08:32 AM EDT
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that data related to the safety and efficacy of AVP-825, a Breath-Powered™ ...